doi:10.1155/2020/2141508 [22] Och A, Och M, Nowak R, Podgrska D, Podgrski R
Fuss IJ, Neurath M, Boirivant M, Klein JS, de la Motte C, Strong SA, et al
Further research, including long-term evaluation of sarcopenia in GLP-1RAs trials, development of standardized monitoring protocols and investigation of combined nutritional, exercise and pharmacologic strategies, is needed in order to prevent muscle loss while maximizing metabolic benefits under GLP-1RAs treatment
Koniver says, before going on to tout its potential cognitive, psychological, and anti-inflammatory benefits
Hybrid pathways may provide capital-efficient access to capabilities and talent, while requiring careful management of governance, execution and alignment risks